铁:辐射治疗的敌人
Lisa Kerkhove1, Febe Geirnaert1, Inès Dufait1
1Department of Radiotherapy, UZ Brussel, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium.
International journal of molecular sciences
|April 13, 2024
概括
铁灭诱导剂在增强放射治疗方面表现有前途,但瘤缺氧可能会阻碍其有效性. 这篇评论探讨了缺氧的情况.
科学领域:
- 生物医学科学 生物医学科学
- 在瘤学瘤学.
- 细胞死亡研究 细胞死亡研究
背景情况:
- 铁,一种依赖于铁的调节细胞死亡,在放射治疗中至关重要.
- 铁致死诱导剂正在作为放射敏感剂进行研究,以改善治疗结果.
- 瘤微环境,特别是缺氧,显著影响铁灭症的诱导.
研究的目的:
- 审查瘤缺氧对ferroptosis诱导的影响.
- 评估ferroptosis诱导剂作为放射敏感剂的临床可行性.
- 为了探索药物用于ferroptosis诱导剂和放射性敏感剂的重新用途.
主要方法:
- 文献综述侧重于铁,缺氧和放射治疗.
- 对ferroptosis诱导剂及其与缺氧条件的相互作用的现有研究进行分析.
- 讨论潜在的不良影响和未来的研究方向.
主要成果:
- 低毒性状况在放射治疗中对ferroptosis诱导构成重大挑战.
- 铁灭诱导剂作为放射敏感剂的有效性是由瘤微环境调节的.
- 药物再利用为基于铁灭的新型放射敏感化策略提供了潜力.
结论:
- 铁死在放射治疗中起着关键作用,但缺氧使其使用复杂化.
- 需要进一步的研究,以克服缺氧诱导的耐铁致死诱导剂的抵抗.
- 铁致死诱导剂具有作为临床放射敏感剂的潜力,等待进一步研究低氧瘤的安全性和有效性.
相关概念视频
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K